Hercules Capital

Type

Venture Capital

Status

Active

Location

Palo Alto, United States

Total investments

249

Average round size

38M

Portfolio companies

219

Rounds per year

11.86

Lead investments

73

Follow on index

0.11

Exits

137

Stages of investment
Debt
Areas of investment
BiotechnologySoftwareHealth CareEnterprise SoftwareManufacturingMedical DeviceMedicalPharmaceuticalTherapeuticsBiopharma

Summary

In 2003 was created Hercules Capital, Inc., which is appeared as VC. The main department of described VC is located in the Palo Alto. The company was established in North America in United States.

The current fund was established by Manuel A. Henriquez, Scott Harvey. Besides them, we counted 5 critical employees of this fund in our database.

The higher amount of exits for fund were in 2010. The important activity for fund was in 2014. Despite it in 2019 the fund had an activity. The usual things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Hercules Capital, Inc. performs on 24 percentage points more the average number of lead investments. Considering the real fund results, this VC is 6 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 7-12 deals per year.

Among the most successful fund investment fields, there are Medical, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Anacor Pharmaceutical, Machine Zone, Zayo. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Hercules Capital, Inc., startups are often financed by VantagePoint Capital Partners, OrbiMed, InterWest Partners. The meaningful sponsors for the fund in investment in the same round are InterWest Partners, Venrock, Kleiner Perkins. In the next rounds fund is usually obtained by Venrock, Steamboat Ventures, General Motors Ventures.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesB2B/EnterpriseFintechClimate techEnergy Show 2 more
Check size
1M — 200M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
249
Lead investments
73
Exits
137
Rounds per year
11.86
Follow on index
0.11
Investments by industry
  • Biotechnology (119)
  • Health Care (108)
  • Pharmaceutical (48)
  • Medical (45)
  • Software (39)
  • Show 196 more
Investments by region
  • United States (215)
  • United Kingdom (12)
  • Germany (2)
  • Switzerland (2)
  • Canada (6)
  • Show 6 more
Peak activity year
2007
Number of Unicorns
18
Number of Decacorns
18
Number of Minotaurs
15

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
18
Avg. valuation at time of investment
311M
Group Appearance index
0.29
Avg. company exit year
11
Avg. multiplicator
0.97
Strategy success index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Cornice 14 Dec 2005 Consumer, Mobile, Video, Electronics Late Stage Venture 97M United States, Colorado
NorthSea Therapeutics 17 Dec 2021 Biotechnology, Health Care, Therapeutics Late Stage Venture 80M North Holland, The Netherlands, Netherlands
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.